126.56
0.00%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Integer Holdings
From its filings with the US Securities and Exchange Commission
Integer Holdings is based in Plano, Texas and is incorporated in Delaware. Its shares trade on NYSE under the ticker ITGR. The SEC classifies its business as electromedical & electrotherapeutic apparatus. In the fiscal year to 31 December 2025, it reported revenue of $1.85bn and net income of $102.8m. At that date it held total assets of $3.41bn and shareholders' equity of $1.75bn. By business, Cardio & Vascular brought in 59.7% of revenue, followed by Cardiac Rhythm Management & Neuromodulation at 36.1% and Other Markets at 4.2%. By region, U.S. accounted for 52.9%, followed by Rest of world at 25.3% and Costa Rica at 9.4%.
Over the past several years, Integer has evolved our portfolio strategy to focus on higher growth medtech markets where we possess differentiated capabilities. Integer continues to execute a tuck-in acquisition strategy that has added capabilities, leading brands and complementary technologies, increased customer penetration, and enhanced scale in our targeted growth markets. These markets are attractive to Integer because they have strong, long-term growth characteristics, and allow us to leverage our existing expertise in process technology and systems engineering to provide comprehensive solutions to our customers. Integer is now a pure-play medical technology company focused on Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets.
On December 4, 2025, we acquired certain assets of Biocoat Incorporated (“Biocoat”). Prior to the acquisition, Biocoat was a privately-held manufacturer specializing in high value surface coating technology platforms, including UV and thermal cure hydrophilic coatings.
On February 28, 2025, we acquired substantially all of the assets and assumed certain liabilities of Vertical Solutions, Inc., d/b/a VSi Parylene (“VSi”). Prior to the acquisition, VSi was a privately-held full-service provider of parylene coating solutions, primarily focused on complex medical device applications.
Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 29 Sept 2000
- Employees
- 11,000
- Website
- integer.net ↗
- Head office
- 5830 GRANITE PARKWAY., SUITE 1150, PLANO, TX, 75024
- Incorporated in
- DE
- Classification
- Electromedical & Electrotherapeutic Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Ms. Pamela BaileyIndependent Chairman of the Board$379,979
- Mr. Payman KhalesPresident, Chief Executive Officer, Director, since 2018$2.0m
- Mr. Diron SmithChief Financial Officer, Executive Vice President$2.5m
- Mr. Jim StephensPresident - Cardiac Rhythm Management & Neuromodulation$1.6m
- Mr. Kirk ThorExecutive Vice President, Chief Human Resources Officer$1.3m
- Ms. Margaret CarthyExecutive Vice President - Quality and Regulatory Affairs
- Mr. John HarrisExecutive Vice President - Global Operations and Manufacturing Strategy, since 2024$1.9m
- Mr. Andrew SennSenior Vice President - Strategy, Business Development and Investor Relations
- Ms. Sheila AntrumIndependent Director$269,924
- Ms. Cheryl CappsIndependent Director$259,924
- Mr. Michael CoyleIndependent Director
- Mr. James HinrichsIndependent Director$294,114
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 40
- Environment
- 14
- Social
- 81
- Governance
- 25
- Direct emissions (scope 1)
- 6,812.977 t
- Energy emissions (scope 2)
- 51,984.73 t
- Women in the workforce
- 48%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Integer Holdings Corp has a strong market position and is a leading player in the medical device industry.
- The company has a diverse product portfolio, offering a wide range of innovative and high-quality medical devices.
- Integer Holdings Corp enjoys strong brand recognition and has established longstanding relationships with key customers.
- The company has a robust distribution network, allowing it to reach customers effectively and efficiently.
Weaknesses
- Integer Holdings Corp is highly dependent on a few key customers for a significant portion of its revenue.
- The company faces regulatory and compliance challenges in the constantly evolving healthcare industry.
- Integer Holdings Corp may experience supply chain disruptions and cost fluctuations due to reliance on third-party suppliers.
- The company's profitability is susceptible to changes in healthcare policies and reimbursement rates.
Opportunities
- The global medical device market is expected to grow due to increasing healthcare expenditure and advancements in technology.
- Integer Holdings Corp can expand its product offerings by investing in research and development to capitalize on emerging healthcare trends.
- The company can explore new market segments and geographic regions to diversify its revenue sources.
- Integer Holdings Corp can leverage partnerships and collaborations to expand its market reach and accelerate innovation.
Threats
- Intense competition in the medical device industry may impact Integer Holdings Corp's market share and pricing power.
- Shifts in customer preferences and demand patterns could negatively affect the company's sales and profitability.
- Stringent regulatory requirements and potential litigation pose risks to the company's operations and financial performance.
- Global economic uncertainties and fluctuations in currency exchange rates may impact Integer Holdings Corp's international operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.